secwatch.observer — SEC 8-K summary
======================================

Issuer:     Altimmune, Inc. (ALT)
CIK:        0001326190
Form:       8-K
Filed at:   2021-12-17T23:59:59+00:00
Accession:  0001104659-21-151231
Event type: other_material
Sentiment:  negative
Materiality: 0.50
Item codes: 1.02
LLM model:  deepseek-v4-flash:cloud@v2

Altimmune terminates Lonza manufacturing agreement for AdCOVID program
----------------------------------------------------------------------

- Terminated Master Services Agreement with Lonza Houston Inc. dated November 5, 2020.
- Associated SOW provided for dedicated manufacturing suite for AdCOVID clinical/commercial supply.
- Termination effective December 17, 2021, following prior discontinuation of AdCOVID program (June 29, 2021).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1326190/000110465921151231/0001104659-21-151231-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1326190/000110465921151231/tm2135808d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-21-151231

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer